Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0001209191-22-011718

Options or other derivatives

  • VP, Controller&Princ Acctg Off acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Weber Steven · VP, Controller&Princ Acctg Off

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-17 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +30,000 30,000 D
Loading xslF345X03/doc4.xml…